14.4 MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
3 Individual results may vary
The Importance of Medical Supervision One of the primary benefits of a telehealth-based program is the ability to have your progress monitored by professionals who understand these medications
Luna Aura Hope Glow Skin Pro nourish your glow from the inside out and embrace a healthier, more radiant you
Induction of glutathione S-transferase and glutathione by toxic compounds and elicitors in reed canary grass
(Netherlands) as the platform operator and STR.VERT CONSULTANTS LTD (Cyprus) as the product seller